BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12969017)

  • 1. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis.
    Kokkola A; Kosunen TU; Puolakkainen P; Sipponen P; Harkonen M; Laxen F; Virtamo J; Haapiainen R; Rautelin H
    APMIS; 2003 Jun; 111(6):619-24. PubMed ID: 12969017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.
    Agréus L; Kuipers EJ; Kupcinskas L; Malfertheiner P; Di Mario F; Leja M; Mahachai V; Yaron N; van Oijen M; Perez Perez G; Rugge M; Ronkainen J; Salaspuro M; Sipponen P; Sugano K; Sung J
    Scand J Gastroenterol; 2012 Feb; 47(2):136-47. PubMed ID: 22242613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome.
    Lo CC; Hsu PI; Lo GH; Lai KH; Tseng HH; Lin CK; Chan HH; Tsai WL; Chen WC; Peng NJ
    World J Gastroenterol; 2005 Aug; 11(30):4715-20. PubMed ID: 16094716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide survey of Helicobacter pylori seropositivity and gastric atrophy in Zambia.
    Kayamba V; Munshi H; Hankolwe MN; Kaluba Kavimba C; Chongwe G; Knaze V; Park JY; Kelly P
    Helicobacter; 2024; 29(3):e13096. PubMed ID: 38790093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel predictive formula for highly accurate discrimination between truly Helicobacter pylori-uninfected and currently infected/spontaneously eradicated individuals for gastric cancer screening.
    Takayama T; Suzuki H; Okada K; Akiyama S; Narasaka T; Maruo K; Sakamoto T; Seo E; Tsuchiya K
    Medicine (Baltimore); 2024 Mar; 103(9):e36335. PubMed ID: 38428882
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Takahashi S; Watanabe K; Fukuda S; Yoshida T; Dohmen T; Fujiwara J; Matsuyama M; Fujimori S; Funaoka M; Shirayama K; Horikawa Y; Fushimi S; Uchikoshi S; Onochi K; Okubo R; Hoshino T; Horii T; Kuramitsu T; Sakaki K; Ishii T; Komatsu T; Yoshida Y; Shirane K; Ono T; Shimodaira Y; Matsuhashi T; Iijima K
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the prevalence of atrophic gastritis and Helicobacter pylori infection over a 10‑year period in Japan: The ROAD study 2005‑2015.
    Inoue I; Yoshimura N; Iidaka T; Horii C; Muraki S; Oka H; Kawaguchi H; Akune T; Maekita T; Mure K; Nakamura K; Tanaka S; Ichinose M
    Mol Clin Oncol; 2023 Jul; 19(1):53. PubMed ID: 37323249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Response of Helicobacter pylori Antibody Titer After Eradication Treatment in Middle-aged Japanese: JPHC-NEXT Study.
    Tanaka S; Goto A; Yamagishi K; Iwasaki M; Yamaji T; Shimazu T; Iso H; Muraki I; Yasuda N; Saito I; Kato T; Aoyagi K; Arima K; Sakata K; Tanno K; Inoue M; Sawada N; Tsugane S
    J Epidemiol; 2023 Jan; 33(1):1-7. PubMed ID: 33907066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of true Helicobacter pylori-uninfected status using a combination of age, serum antibody and pepsinogen: Logistic regression analysis.
    Takayama T; Suzuki H; Okada K; Yamada T; Maruo K; Saito Y; Mizokami Y
    PLoS One; 2020; 15(10):e0240040. PubMed ID: 33002056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Anti-Helicobacter pylori IgG Antibody Titer in H. pylori-negative Cases with a Different Gastric Mucosal Atrophy Status.
    Adachi K; Kishi K; Notsu T; Mishiro T; Sota K; Ishimura N; Ishihara S
    Intern Med; 2020 Nov; 59(22):2817-2823. PubMed ID: 32713919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review with Meta-analysis: Association of Helicobacter pylori Infection with Esophageal Cancer.
    Gao H; Li L; Zhang C; Tu J; Geng X; Wang J; Zhou X; Jing J; Pan W
    Gastroenterol Res Pract; 2019; 2019():1953497. PubMed ID: 31871444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for gastric precancerous and cancers lesions in Latin American counties with difference gastric cancer risk.
    Flores-Luna L; Bravo MM; Kasamatsu E; Lazcano Ponce EC; Martinez T; Torres J; Camorlinga-Ponce M; Kato I
    Cancer Epidemiol; 2020 Feb; 64():101630. PubMed ID: 31756677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Previous Helicobacter pylori infection-induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication.
    Kishikawa H; Ojiro K; Nakamura K; Katayama T; Arahata K; Takarabe S; Miura S; Kanai T; Nishida J
    Helicobacter; 2020 Feb; 25(1):e12669. PubMed ID: 31680399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan.
    Sugawara K; Koizumi S; Horikawa Y; Mimori N; Tsuji T; Ishii H; Fujimori S; Onochi K; Watanabe H; Iijima K
    J Gastroenterol; 2019 Nov; 54(11):963-971. PubMed ID: 31037448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between Quantitative
    Boltin D; Levi Z; Perets TT; Schmilovitz-Weiss H; Gingold-Belfer R; Dickman R; Dotan I
    Gastroenterol Res Pract; 2018; 2018():5439539. PubMed ID: 30538739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection.
    Kikuchi S; Kato M; Mabe K; Kawai T; Furuta T; Inoue K; Ito M; Yoshihara M; Kodama M; Murakami K
    J Epidemiol; 2019 Apr; 29(4):147-154. PubMed ID: 30249942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Portugal.
    Nogueira C; Mota M; Gradiz R; Cipriano MA; Caramelo F; Cruz H; Alarcão A; E Sousa FC; Oliveira F; Martinho F; Pereira JM; Figueiredo P; Leitão M
    Infect Agent Cancer; 2017; 12():41. PubMed ID: 28814970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnifying NBI Patterns of Gastric Mucosa After Helicobacter pylori Eradication and Its Potential Link to the Gastric Cancer Risk.
    Tahara T; Tahara S; Tuskamoto T; Horiguchi N; Yoshida D; Kawamura T; Okubo M; Nagasaka M; Nakagawa Y; Urano M; Kuroda M; Shibata T; Ohmiya N
    Dig Dis Sci; 2017 Sep; 62(9):2421-2427. PubMed ID: 28702753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnifying narrow-band imaging of gastric mucosal morphology predicts the H. pylori-related epigenetic field defect.
    Tahara T; Yamazaki J; Tahara S; Okubo M; Kawamura T; Horiguchi N; Ishizuka T; Nagasaka M; Nakagawa Y; Shibata T; Kuroda M; Ohmiya N
    Sci Rep; 2017 Jun; 7(1):3090. PubMed ID: 28596594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel CagA ELISA exhibits enhanced sensitivity of
    Matsuo Y; Kido Y; Akada J; Shiota S; Binh TT; Trang TT; Dung HD; Tung PH; Tri TD; Thuan NP; Tam LQ; Nam BC; Khien VV; Yamaoka Y
    World J Gastroenterol; 2017 Jan; 23(1):48-59. PubMed ID: 28104980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.